NSTD Company Profile

Fading Diminishing Returns at the Tivic Health Systems Inc over the financial span closing December 31 2022

For the financial span closing December 31 2022 TIVC decreased a loss per share of $-0.18 per share compare to $-1.04 a year prior and EPS improved from $-0.27 per share from the prior reporting season.

Sales dropped sharply by -72.174 % to $0.51 millions from $1.84 millions in the corresponding reporting season a year prior and sequentially Sales advanced by 7.338 % from $0.48 millions.

The evolving business from the Biotechnology & Pharmaceuticals sector the Eloxx Pharmaceuticals Inc published the financial period ending fourth quarter of 2022, results

While the earnings cycle of fiscal October to December 31 2022 season resumes, the most entities have announced the respective numbers. In the thick of it, are many businesses in the Biotechnology & Pharmaceuticals industry. And now, Eloxx Pharmaceuticals Inc reported operating shortfall of $-6.028 millions, for the fourth quarter of 2022.

The Losses have enlarged even more at the Kineta Inc during the financial fourth quarter of 2022

KA announced very solid Sales elevation of 155.963 % year on year to $1.95 millions in the fourth quarter of 2022, but increased a loss per share at $-8.49.

Formidable Sales growth by 14.483%, at Odyssey Marine Exploration Inc in the financial fourth quarter of 2022

Although company's Sales increased by 14.483 % from the similar quarter a year prior to $0.29 millions in the October to December 31 2022, Odyssey Marine Exploration Inc Diminishing Returns have swelled at $-0.18 deficit per share.

In the October to December 31 2018 company Deficit has extended at $-0.16 per share, opposite of $0.00 per share a year before reporting season, In the preceding reporting season New York Reit Liquidating Llc realized $-0.16 per share.